Latest Forum Topics /
SGX
Last:25.0
+0.05
|
 Post Reply
|
|
SGX
|
|||||
|
lifeisgood
Supreme |
20-Aug-2026 14:12
|
||||
|
x 0
x 0 Alert Admin |
I think MAS gave some money to JP Morgan, which put a large chunk of it into a quant trading fund. Those funds only trades in very liquid stocks, meaning stocks that never had any liqudity in the first place will never get a chance at all. | ||||
| Useful To Me Not Useful To Me | |||||
|
stlimst
Master |
20-Aug-2026 13:36
|
||||
|
x 0
x 0 Alert Admin |
With the banks and SGX propping up the index, do you really need the EQDP intervention?
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
Alignment
Elite |
20-Aug-2026 12:45
|
||||
|
x 0
x 0 Alert Admin |
EQDP a waste of money. Paying foreign managers to invest in stocks that largely did not need it. | ||||
| Useful To Me Not Useful To Me | |||||
|
cfdking
Veteran |
20-Aug-2026 11:53
|
||||
|
x 0
x 0 Alert Admin |
so long index is alright...their KPi achieved..u think they bother | ||||
| Useful To Me Not Useful To Me | |||||
|
stlimst
Master |
20-Aug-2026 11:47
|
||||
|
x 0
x 0 Alert Admin |
MAS EQDP was like a prematured baby. Never had a chance to grow.
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
lifeisgood
Supreme |
20-Aug-2026 11:36
|
||||
|
x 0
x 0 Alert Admin |
Is MAS EQDP dead? Seems like many small and mid cap stocks have fallen back to near ZERO daily trading liquidity. Big winners are DBS and SGX, which dont need EQDP in the first place. |
||||
| Useful To Me Not Useful To Me | |||||
|
teeth1953
Senior |
07-Aug-2026 14:34
|
||||
|
x 0
x 0 Alert Admin |
initiatives, which freed up substantial cash to reward shareholders.
*✓ >Key Financial Highlights Reported Net Profit: Rose 7.8% y-on-y to S$698.4 million.
Adjusted Net Profit: Surged 24.6% y-on-y to S$759.5 million.
*✓ >Net Revenue: Increased 13.9% to S$1.48 billion, crossing S$1.5 billion mark in gross operating revenue for the first time.
*✓ >Adjusted Earnings Per Share (EPS): Jumped to S$0.71, up from S$0.57 in FY2025.
*✓ >Dividend Breakdown: Following SGX Group Earnings Announcement, board proposed an enhanced payout structure subject to approval at upcoming Annual General Meeting on *✓ >October 23, 2026<..
*✓ >Dividend Type: Per Share Status Final Quarterly Dividend S$0.115 (up from S$0.105 last yr). Proposed (HERE One-off). ✓ ✓ >>Additional Dividend S$0.125 (funded by capital recycling)Proposed Total FY2026.
*✓ >Payout S$0.570 (up 52% from S$0.375 in FY2025)
*✓ >Cumulative: Note: If approved, both the final and special dividends are scheduled for payout on >>>November 10, 2026<<<.
|
||||
| Useful To Me Not Useful To Me | |||||
|
chengwh1
Elite |
06-Aug-2026 23:01
|
||||
|
x 0
x 0 Alert Admin |
Thanks be to God,... today, two of my major hldgs published record results, namely DBS & SGX,.......... | ||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
chengwh1
Elite |
06-Aug-2026 22:57
|
||||
|
x 0
x 0 Alert Admin |
Frankly speaking,... I do not have a strong grasp on the business activities and thesis for SGX, unlike all the other issuers that I am holding. I only know that there is momentum in this issuer, and when there is mkt volatility, the share price will move up. Hence, I invested and held-on,... my dividend yield-on-cost is slowly creeping up as time goes by. | ||||
| Useful To Me Not Useful To Me | |||||
|
spursfan
Supreme |
06-Aug-2026 21:11
|
||||
|
x 0
x 0 Alert Admin |
FY2026 Results https://links.sgx.com/1.0.0/corporate-announcements/J2GBKSSQKW6F3T4H/898861_1.%20SGX%20Group%20reports%20FY2026%20net%20profit%20of%20S%24759%20million.pdf |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
22-Jul-2026 09:50
|
||||
|
x 0
x 0 Alert Admin |
RHB raises SGX target price on record market performance, Scientific Beta divestment [SINGAPORE] RHB raised its target price on the Singapore Exchange (SGX) to S$22.50 from S$22.20 while maintaining its &ldquo neutral&rdquo call, it said in a note on Tuesday (Jul 21). The research house noted that SGX&rsquo s June market statistics came in &ldquo stronger than expected&rdquo , capping a record FY2026 for the bourse. The total securities market trading value jumped 72 per cent year on year to S$44.6 billion. Derivatives traded volume jumped 31 per cent year on year, and the derivatives daily average volume (DDAV) climbed 27 per cent year on year to 1.6 million contracts. On the cash equities side, the securities daily average value (SDAV) spiked by 72 per cent year on year to S$2.1 billion. This surge in trading activity aligns closely with broader market exuberance. According to the latest SGX market update on Monday, the Straits Times Index (STI) has been scaling record highs past June. &ldquo The Straits Times Index (STI) reached a record high of 5,561.42 on 15 July and, and delivered a 21.2 per cent total return through 17 July, including an 18.6 per cent price gain,&rdquo SGX said. RHB highlighted that trading activity has &ldquo broadened meaningfully&rdquo , with retail SDAV surging 52 per cent year on year to a 12-year high. Retail investors have remained net buyers for five consecutive months, contributing S$2.4 billion in cumulative net inflows for FY2026. Positive on Scientific Beta divestment Adding to the positive fundamental outlook is SGX&rsquo s strategic divestment of its wholly owned subsidiary, Scientific Beta, to Stoxx AG for about 23 million euros (US$26.3 million). RHB views this move positively as it removes &ldquo a likely earnings drag and sharpens management&rsquo s strategic focus.&rdquo Scientific Beta recorded a net loss of around S$15 million in the first half of FY2026. Factoring in the robust June statistics, the RHB analyst has raised SGX&rsquo s net profit forecasts for FY2026, FY2027, and FY2028 by 1.4 per cent, 1.3 per cent, and 1.2 per cent, respectively. Despite the strong operational performance, RHB remains cautious about valuation constraints. SGX is currently trading at roughly 29 times FY2027 forecasted earnings, which represents a 19 per cent premium over its ex-India regional peers. &ldquo While the premium is defensible on the basis of scarcity value and structural tailwinds from Singapore&rsquo s regulatory support initiatives, we believe its share price already reflects the improving earnings trajectory. We would turn more constructive if consensus earnings move materially higher, or if the share price corrects meaningfully,&rdquo RHB said. |
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
14-Jul-2026 11:52
|
||||
|
x 0
x 0 Alert Admin |
SGX securities trading value jumps 72% in June, caps &lsquo stellar&rsquo FY2026 [SINGAPORE] Robust trading activity across both cash equities and derivatives in June propelled the Singapore Exchange (SGX) to a strong finish for its 2026 financial year, the local bourse said on Monday (Jul 13). The total securities market trading value jumped 72 per cent year on year to S$44.6 billion. The surge capped what SGX : S68 +0.08% described as a &ldquo stellar performance&rdquo for the financial year, as global investors increasingly &ldquo leaned on trusted risk-management tools&rdquo . Securities daily average value (SDAV) surged 72 per cent year on year to S$2.1 billion. For the full 2026 financial year, SDAV gained 35 per cent year-on-year to S$1.8 billion. This was the &ldquo highest in 18 years&rdquo , the bourse operator highlighted. Total turnover for FY2026 climbed 35 per cent year on year to S$455.7 billion. STI hits new high The benchmark Straits Times Index (STI) extended its rally, hitting an all-time high of 5,218.96 on Jun 25 before ending the month at 5,170.65. This represented a 30.4 per cent year-on-year jump. SGX attributed this performance to &ldquo supportive growth and structural investment themes&rdquo that continued to effectively outweigh external headwinds, lifting total returns over the 12-month period to 36.4 per cent. Trading activity broadened significantly beyond blue-chip counters. This was supported by a double-digit growth in SDAV, across both retail and institutional investors. Retail investors were a key driving force, maintaining a net buying streak for five consecutive months up to June and pouring in S$2.4 billion in cumulative net inflows for the financial year. Retail SDAV surged 52 per cent to its highest level in 12 years. Institutional interest also spilled heavily into small- and mid-cap stocks. Institutional net buying in this segment climbed three times to S$606 million, compared with S$200 million in FY2025. This drove small- and mid-cap SDAV up 155 per cent to S$310 million, a high not seen since FY2014. &ldquo Reflecting stronger investor interest beyond the benchmark index, the iEdge Singapore Next50 index advanced 23.8 per cent year on year in June to 1,516.01,&rdquo SGX added. Over in the derivatives market, total trading volume rose 31 per cent year on year to 34.3 million contracts in June, while daily average volume climbed 27 per cent to 1.62 million contracts. In the foreign exchange (FX) space, SGX noted that &ldquo uncertainty over Asian currency valuations, amid a mixed outlook for global interest rates,&rdquo supported robust hedging activity across its renminbi, rupee, and won futures complexes. Total FX futures volume for FY2026 climbed 31 per cent year on year to 96.3 million contracts. Commodities also had a record year across benchmark iron ore derivatives, forward freight agreements, as well as petrochemicals and dairy contracts. SGX said the gains were &ldquo driven by increased hedging and trading activity amid disruptions to global physical supply chains, while continued expansion in the client base further propelled financialisation&rdquo . Total commodities volume for the financial year increased 21 per cent year on year to 78.8 million lots. Meanwhile, assets under management (AUM) across exchange-traded funds (ETFs) surpassed S$20.5 billion at the end of June. Net inflows surged 240 per cent year on year in the second half of FY2026 to S$2.4 billion, with combined AUM of STI ETFs exceeding S$5 billion to mark a 15th straight month of net inflows. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
stlimst
Master |
14-Jul-2026 11:13
|
||||
|
x 0
x 0 Alert Admin |
A stellar record on SGX volume of business but share price plummet. Sell on news? | ||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
04-Jul-2026 14:16
|
||||
|
x 0
x 0 Alert Admin |
SGX enjoys higher target prices again with volume surge Analysts from DBS Group Research and RHB Bank Singapore have raised their target prices on Singapore Exchange (SGX) as they see the Equity Market Development Programme (EQDP) continuing to anchor the exchange&rsquo s securities daily average value (SDAV). On June 10, SGX reported an SDAV of $2.4 billion for May, up 79% y-o-y and the highest since October 2007. &ldquo [The] SDAV is a key driver of SGX&rsquo s stock price,&rdquo says DBS analyst Lim Rui Wen, who has a &ldquo buy&rdquo call and a higher target price of $26.40, up from $22.50. SGX, Singapore&rsquo s sole exchange operator, is set to benefit from several catalysts, including the EQDP, which is only in its early stages. &ldquo The resurgence in Singapore equities has been notable, with stronger retail and institutional participation, improving liquidity, unprecedented government support and a coordinated ecosystem-wide effort lifting SDAV from its long-term through-cycle average of $1.2 billion to over $2 billion currently,&rdquo she says. &ldquo In our view, these early signs of success strengthen rather than diminish the case for further policy support.&rdquo Of the $6.5 billion EQDP, only one-third has been deployed into the market so far from the first two rounds of disbursements. This excludes any additional private capital raised alongside the programme, Lim adds. The third round of asset managers is tipped to be announced by mid-2026. &ldquo We believe that a vibrant and liquid domestic equity market is a critical pillar of Singapore&rsquo s ambitions to reinforce its position as Asia&rsquo s leading wealth and financial hub, attracting both capital inflows and new listings,&rdquo says Lim, who adds that further expansion of the EQDP is a &ldquo distinct possibility&rdquo . Derivatives drive SGX&rsquo s derivatives arm is also doing well, with derivatives traded volume increasing by 20% y-o-y to 30.5 million contracts in May. Derivatives daily average volume (DDAV) gained 27% y-o-y to 1.6 million, the third-largest on record. Lim believes the exchange will continue to benefit from the current volatility and Singapore dollar (SGD) safe-haven inflows, which she sees as &ldquo structural&rdquo in nature. Given this, the analyst foresees continued flows into Singapore, especially into yield stocks, amid lower confidence in the US dollar (USD) amid ongoing de-dollarisation trends and the re-evaluation of US creditworthiness and policy credibility. Amid these trends, Lim believes the SGX stands to be a &ldquo key beneficiary&rdquo , especially in the current low-interest rate environment. Demand for risk management tools will also remain high amid uncertainties stemming from the war in Iran, she adds. In addition to her target price lift, Lim has also increased her FY2026&ndash FY2027 earnings per share (EPS) estimates by 1%&ndash 4% to 68.68 cents and 77.42 cents, respectively. Her new target price is based on an FY2027 P/E of around 34 times, or 2 standard deviations (s.d.) above SGX&rsquo s historical forward P/E. &ldquo We believe the structural changes and Singapore market inflows will continue to fuel SGX&rsquo s multiple and EPS rerating, amidst strong derivatives business growth,&rdquo she reiterates. &ldquo We believe that the premium P/E to peers is justified with 8%&ndash 13% net profit growth expected across FY2027&ndash FY2028 as SGX enters a new stage of growth. Further capital management initiatives may represent additional catalysts,&rdquo she adds. Meanwhile, RHB analyst Shekhar Jaiswal has raised his target price to $22.20 from $20.90, citing &ldquo meaningful&rdquo increases to his SDAV estimates. &ldquo Our model now reflects 10% and 14% jumps in SDAV assumptions for FY2027 and FY2028, reflecting our confidence in the durability of the current elevated trading environment,&rdquo he writes in his June 26 report. The analyst&rsquo s report follows a meeting with SGX&rsquo s management, during which he also raised his profit forecasts by 6.2% and 7.6% for FY2027 and FY2028. His forecasts, which now stand at $883 million and $968 million for both years, respectively, follow the higher SDAV estimates. In a June 12 report issued after SGX&rsquo s May statistics, Jaiswal noted SGX&rsquo s &ldquo stretched&rdquo valuations. To him, the counter&rsquo s &ldquo elevated&rdquo multiple &ldquo adequately reflects the structural improvements in market activity&rdquo . The stock will have to see a &ldquo sustained upward revision cycle&rdquo in consensus earnings or a &ldquo meaningful correction&rdquo in its share price for RHB to adopt a more constructive stance. EQDP anchor In his latest report, Jaiswal, like Lim, believes the EQDP will continue to anchor SDAV. There will also be a &ldquo genuine broadening&rdquo of investor participation in stocks beyond the benchmark Straits Times Index&rsquo s (STI) constituents, as reflected in the index&rsquo s share of total value traded declining to 74% from 85% a year ago. Jaiswal also points out that retail activity has reached 13-year highs while institutional investors have been net buyers of small- and mid-cap (SMID) stocks for five consecutive months. Net new listings and secondary market capital raising have also picked up. The positive volume impact is, however, partly offset by a higher tax rate and cost growth tracking the upper end of its guidance range. Jaiswal notes that SGX&rsquo s capital expenditure (capex) could also remain elevated in the near term. &ldquo SGX indicated that the tax rate for 2HFY2026 and beyond would be 18%, up from our previous 17% assumption&rdquo . &ldquo We adjusted our cost assumptions higher, with FY2026 expense growth now modelled towards the upper end of the 4%&ndash 6% guidance range. Together with elevated capex in the near term, these factors temper the earnings benefit from higher SDAV assumptions, particularly in FY2026, where the net profit uplift is a modest 1.5%,&rdquo he says. Jaiswal&rsquo s new target price, which still represents a downside of 5.18% to SGX&rsquo s last-closed share price of $24.15 as at June 28, is still based on an FY2027 P/E of 26 times. It also includes an environmental, social and governance (ESG) premium of 4%. The target P/E remains elevated at 2 s.d. above SGX&rsquo s 12-year forward P/E average. &ldquo SGX trades at a premium to the ex-India regional peers&rsquo weighted average P/E. The premium extends to P/BV, despite SGX&rsquo s ROE (return on equity) being broadly in line with peers. The dividend yield also trails the peer average, though this gap should narrow as payout expands over the next few years,&rdquo says Jaiswal. &ldquo The premium is defensible on scarcity value and franchise quality, but the current share price already capitalises the structural reform narrative.&rdquo Despite the target price increase, Jaiswal still sees &ldquo limited scope&rdquo for further rerating, as his estimates already sit above consensus. &ldquo Our FY2027 and FY2028 net profit forecasts are 8.5% and 10% above consensus, respectively,&rdquo he says. &ldquo We would turn more constructive only if consensus earnings move materially higher, or if the share price corrects enough to restore positive expected returns on our unchanged valuation framework.&rdquo |
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
17-Jun-2026 18:03
|
||||
|
x 0
x 0 Alert Admin |
NASDAQ is more than double the size of SGX. It' s like one is the tiger and the other is the chital at the night safari. I wonder sometimes if the chital is stressed out all the time as it presumably can smell the tiger is nearby
|
||||
| Useful To Me Not Useful To Me | |||||
|
MrBear12
Supreme |
17-Jun-2026 02:35
Yells: "Cast all our anxieties on Jesus for He cares for us" |
||||
|
x 0
x 0 Alert Admin |
or SGX may buy Nasdaq
|
||||
| Useful To Me Not Useful To Me | |||||
|
Alignment
Elite |
16-Jun-2026 21:00
|
||||
|
x 0
x 0 Alert Admin |
Perhaps NASDAQ at some point may buy SGX. | ||||
| Useful To Me Not Useful To Me | |||||
|
tongphlp
Supreme |
16-Jun-2026 17:42
|
||||
|
x 0
x 0 Alert Admin |
haha..Jun would be down because of world cup fever...
|
||||
| Useful To Me Not Useful To Me | |||||
|
muifan
Supreme |
16-Jun-2026 17:36
Yells: "Take the leap of faith dont regret 20 years later!" |
||||
|
x 0
x 0 Alert Admin |
The bb that wiped all out in matching so powerful | ||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
16-Jun-2026 10:07
|
||||
|
x 0
x 0 Alert Admin |
Analysts mostly lift SGX&rsquo s TPs after &lsquo strong&rsquo May trading stats Analysts are mostly bullish over Singapore Exchange&rsquo s (SGX) prospects after the exchange reported a &ldquo strong&rdquo set of numbers in May. During the month, securities market turnover rose by 70.4% y-o-y to $45.8 billion. Securities daily average value (SDAV) increased by 79.4% y-o-y to $2.4 billion, the highest since October 2007. Derivatives traded volume was also up by 20% y-o-y to 30.5 million contracts while daily average volume grew by 27% to 1.6 million contracts, the third-highest on reocrd. Maybank Securities&rsquo Thilan Wickramasinghe was the most optimistic with a &ldquo buy&rdquo call and a higher target price of $25.25, from $20.37 previously. His target price factors in rolled forecasts to FY2027, a lower weighted average cost of capital (WACC) to 5.9% from 6.6%, a terminal rate of 1% and a lowered P/E multiple of 21 times. The lower WACC was due to lower market risk premium. &ldquo SGX&rsquo s May equity market turnover shows an accelerating trend towards a higher baseline velocity. This should drive structurally higher SDAV in the medium term,&rdquo he writes in his June 12 report. Mainboard velocity stood at 56%, which shows that large-cap institutional participation remains strong. Catalist velocity was 73%, compared to the 21% reported just a year ago. &ldquo This indicates higher retail participation, given the board&rsquo s smaller cap listings,&rdquo says Wickramasinghe. &ldquo While there is no breakdown of institutional versus retail shareholders in the Mainboard, we extrapolate that retail liquidity is shifting up to a higher base.&rdquo The analyst adds that flows due to Singapore&rsquo s status as a safe haven, market reforms, as well as corporate restructuring and value unlocking are a &ldquo self-reinforcing trifecta&rdquo that should drive market average daily value (ADV) further. Given this, Wickramasinghe has upgraded his FY2026 to FY2028 ADV estimates by 10% to 18% to over $2 billion. In May, SGX&rsquo s deriatives also saw &ldquo strong growth&rdquo , which reflects &ldquo broad demand&rdquo for managing risk across asset classes. With elevated global volatility such as the recent re-escalation between the US and Iran, Wickramasinghe believes SGX&rsquo s multi-asset platform is a &ldquo structural beneficiary&rdquo . The continued market momentum leading to SGX&rsquo s 2HFY2026 results - slated to be released on Aug 6 - may lead to consensus upgrades, he adds. A key risk, he notes, are recent IPOs trading below their opening price, which may affect IPO momentum and liquidity availability going forward. This, he adds, may also seep through to secondary market velocity. Of the total IPOs launched in 2025 and 2026, 66% of them are trading below their opening price year to date. UOB Kay Hian&rsquo s Roy Chen has maintained a &ldquo hold&rdquo call but with a higher target price of $21.70 from $19.16 previously as SGX&rsquo s cumulative trading statistics for the past 11 months ended May beat expectations. Chen expects trading activities to sustain in the rest of FY2026 and FY2027 with the initiatives from the Monetary Authority of Singapore and SGX expected to continue driving investor participation and market liquidity for the rest of the year and beyond. On derivatives, the global uncertainties will sustain risk management demand through trading, Chen adds. For its FY2026 results, Chen expects SGX&rsquo s core earnings to grow by 21.2% y-o-y to $739 million. Headline net profit is expected to grow by 11.8% y-o-y to $724 million, he says. Core earnings would be driven by top-line growth of 13.5% y-o-y and operating margin expansion of 2.5 percentage points y-o-y due to favourable opearting leverage. Chen&rsquo s new target price is based on an FY2028 P/E estimate of 27.1 times, pegged to 2 standard deviations (s.d.) above SGX&rsquo s historical mean P/E of 22.3 times. &ldquo The +2 s.d. peg reflects SGX&rsquo s upbeat earnings growth outlook and its unique valuation proposition being a beneficiary of both Singapore&rsquo s equity market development initiatives and heightened macro and geopolitical uncertainties,&rdquo he writes. &ldquo While we see no de-rating catalyst for SGX in the near term, we think positives for the company should have been well digested by the market and hence likely been priced in. In addition, SGX&rsquo s FY2028 P/E of 27.1 times is also a premium over its global peers which are mostly trading at 18 times - 24 times,&rdquo he adds. &ldquo As such, we will seek a better entry point to invest in SGX.&rdquo RHB Bank Singapore&rsquo s Shekhar Jaiswal remains &ldquo neutral&rdquo on SGX with an unchanged target price of $20.90. Despite the strong data, which is now trading 8.1% and 5.7% ahead of his estimates for securities and deriatives respectively, Jaiswal believes SGX&rsquo s valuations are &ldquo stretched&rdquo . His target price, which continues to be based on an FY2027 earnings per share (EPS) estimate of 26 times and at 2 s.d. above SGX&rsquo s 12-year foward P/E average, remains &ldquo elevated&rdquo . This, to Jaiswal, &ldquo adequately reflects the structural improvements in market activity&rdquo . That said, the analyst sees upside risk to his FY2026 net profit forecast of $734 million. &ldquo We maintain that while the improvements in market breadth and trading intensity are encouraging, the elevated valuation probably reflects much of this positive momentum.&rdquo Morningstar analyst Roy Van Keulen has also left his &ldquo two star&rdquo rating unchanged on SGX. He has, however, lifted his fair value estimate for the &ldquo wide-moat&rdquo SGX by 5% to $16.80 after the exchange has continued to perform above expectations. At its share price of $21.70 as at Van Keulen&rsquo s report on June 10 and at $23.25 as at June 15, the analyst believes SGX&rsquo s shares are &ldquo materially overvalued&rdquo . &ldquo Our slight upgrade comes from our growing conviction that the exchange is not merely benefiting from one-off cyclical factors, but that elevated volatility is a structural growth driver for volumes and earnings,&rdquo he explains. Shares in SGX closed 67 cents higher or 2.97% up at $23.25 on June 15. |
||||
| Useful To Me Not Useful To Me | |||||